Search For

Advanced glycation endproduct-RAGE signaling fosters diabetic cardiomyopathy by enhancing cuproptosis and mitochondrial injury

Genetic predisposition to diabetes mellitus causally increases acute pancreatitis risk

Alterations in the serum lipid profile predict incident diabetes in obese individuals

Should we shift from delaying diabetes to pursuing pre-diabetes remission for cardiovascular disease prevention?

On the potential of group-specific component (GC) inhibition for treating metabolic disease

Timing of physical activity and cardiovascular and mortality risk in patients with type 2 diabetes: a UK biobank cohort study

Liver fibrosis and diabetic peripheral neuropathy in individuals with type 2 diabetes mellitus: an observational, cross-sectional study

The cross-talk between neurodegeneration and metabolic disorders

The global burden of diabetes-related chronic kidney disease from 1990 to 2021, with projections to 2036

Type 1 diabetes mellitus: the liver’s role, sex-specific outcomes, and advances in disease-modifying therapies - a literature review

Evolving models of care in patients with metabolic dysfunction-associated steatotic liver disease, recognising its population burden and the impact of metabolic dysfunction on incident rates of hepatic and extrahepatic outcomes

Regulatory T cell-based therapies for type 1 diabetes: a narrative review